Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2010-06-18 M&A Activity
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
M&A Activity 2010
M&A Activity Classification · 99% confidence The document is explicitly titled as a 'Press release' dated June 18, 2010, announcing a specific corporate action: 'Vitrolife enters into a collaboration agreement with the Danish company HertART Aps and acquires a participation in the company.' This describes a transaction involving acquisition and partnership, which falls under corporate activity related to financing, investment, or M&A. Since it is a press release announcing a transaction (acquiring a 25% stake and an option for more), it is best classified as a Capital/Financing Update (CAP) or potentially M&A Activity (TAR). Given the focus is on acquiring a participation/stake and collaboration rather than a full takeover bid, CAP is a strong fit, as it relates to capital structure changes and fundraising activities (even if it's an acquisition of equity). However, the core event is the acquisition of a stake in another company, which is a form of M&A activity. Reviewing the definitions, TAR is for 'merger proposals or takeover bids.' CAP is for 'fundraising, financing activities, or capital structure changes.' Since this is an acquisition of a minority stake, it is a change in capital structure/investment. If a more specific M&A code existed for minority stake acquisitions, it would be preferred. Given the options, 'CAP' (Capital/Financing Update) covers the acquisition of a participation better than 'TAR' (which implies a full merger/takeover bid). Alternatively, since it is a general corporate announcement that doesn't fit the highly specific financial report types (10-K, IR, ER), it could fall under RNS (Regulatory Filings) if it were purely a notification requirement. However, the content is substantive about a transaction. I will classify it as CAP as it involves acquiring a participation/stake, which impacts capital structure/investment strategy. If the document were purely a notification that this press release was published, it would be RPA/RNS, but the content itself is the announcement of the transaction.
2010-06-18 English
M&A Activity 2010
M&A Activity Classification · 99% confidence The document is a 'Pressmeddelande' (Press Release) dated June 18, 2010, announcing a strategic collaboration agreement and the acquisition of a 25% stake in HertART Aps. This describes a corporate transaction involving partnership and equity purchase, which falls under the category of M&A Activity (Takeover/Merger/Acquisition related announcements). The definition for M&A Activity (TAR) covers merger proposals or takeover bids, and this transaction, involving an acquisition of a significant stake and collaboration, aligns best with this category rather than general financing (CAP) or insider trading (DIRS). Since it is a specific announcement of a transaction, it is not a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2010-06-18 Swedish
Regulatory Filings 2010
Regulatory Filings Classification · 88% confidence The document is a 'Press Release' dated June 14, 2010, announcing a 'collaboration agreement' between Vitrolife and the University of Melbourne regarding stem cell media development. This is not a standard regulatory filing like a 10-K, an earnings release (ER), or a formal report (AR, IR). It announces a specific business development or partnership. Among the provided categories, this type of announcement—a specific business event or agreement—does not fit neatly into the financial reporting codes (10-K, IR, ER) or governance codes (MANG, DIRS). It is a general corporate announcement. Since it is not a report itself, and it doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), the most appropriate fallback category for a general, non-standard corporate announcement is Regulatory Filings (RNS), which serves as the miscellaneous category for announcements that don't fit elsewhere.
2010-06-14 English
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a press release (Pressmeddelande) dated June 14, 2010, announcing a specific business event: Vitrolife signing a collaboration agreement with the University of Melbourne regarding stem cell media development. This is not a standard regulatory filing like a 10-K, an earnings release (ER), or a formal report (AR, IR). It is a specific corporate announcement regarding business development/partnership. Since there is no specific category for 'Business Development Announcement' or 'Partnership Agreement', and it is not a management change (MANG), financing event (CAP), or insider trade (DIRS), the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous regulatory or significant corporate announcements that don't fit the highly specific codes provided. The document length is short (2842 chars), but it contains the full substance of the announcement, not just a notice to download another report.
2010-06-14 Swedish
Regulatory Filings 2010
Regulatory Filings Classification · 92% confidence The document is titled "Pressmeddelande" (Press Release) dated May 19, 2010, and announces clinical study results regarding the STEEN Solution™ method for lung transplantation. It provides key findings, context about the study (HELP study presented at ISHLT), and company background. This format—a brief announcement of significant news or results—aligns best with an Earnings Release (ER) if it were financial results, but since it is a scientific/operational announcement, it fits the general category of a regulatory or significant corporate announcement that isn't a formal financial report (like 10-K or IR) or a specific management discussion (MDA). Given the options, and since it is a formal announcement of a significant development (study results), it is most appropriately classified as a general Regulatory Filing (RNS) as it is a public disclosure of material information that doesn't fit the other specific categories like DIV, CAP, or ER (which usually focuses strictly on financial metrics). It is not a short announcement pointing to a larger report, but the report itself (a press release detailing findings). RNS is the best fit for general, non-standardized regulatory/material disclosures.
2010-05-19 Swedish
Legal Proceedings Report 2010
Legal Proceedings Report Classification · 99% confidence The document is explicitly labeled as a "Press release" dated May 19, 2010, announcing clinical study results regarding the STEEN Solution™ method for lung transplantation. It provides key findings, study details (HELP study), and contact information for the CEO and CFO. This format—a brief announcement of significant, non-periodic operational or clinical news—most closely aligns with an Earnings Release (ER) if it were financial, but since it is clinical/operational news, it fits best under the general regulatory announcement category, RNS, as it is not a formal financial report (10-K, IR, MRQ), a management discussion (MDA), or a specific legal/governance filing. Given the options, RNS (Regulatory Filings) serves as the best general category for non-standard press releases that convey material, non-financial operational updates.
2010-05-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.